The annual NEURAL Conference is the only regional neuroscience graduate trainee conference of its kind and the cornerstone of the efforts put forth by the UAB Neuroscience Roadmap Scholars Program.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...
ATLANTA, April 23, 2025 /PRNewswire/ -- The Atlanta Neuroscience Foundation (ANF) proudly announces the return of its highly anticipated World Neuroscience Day Conference, taking place Saturday, May 3 ...
Novartis has significantly strengthened its neuroscience pipeline over recent years, topped by the $12bn acquisition of ...
With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients’ suffering. LONDON ...
MarketsandMarkets Conferences, is thrilled to announce ETAP-Lab as the distinguished Speaking Partner for the upcoming 6th Annual Neuroscience R&D Conference. The MarketsandMarkets Neuroscience R&D ...
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto’s ...
Format: Fireside chat and one-on-one investor meetings Presentation Date & Time: Wednesday, September 17, 2025, at 1:20 pm ET Available presentations will be accessible via a live webcast on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results